X0306
4
2020-07-23
0001682852
Moderna, Inc.
MRNA
0001760669
Hoge Stephen
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
President
Common Stock
2020-07-23
4
M
0
10000
.99
A
1986530
D
Common Stock
2020-07-23
4
S
0
1043
75.58
D
1985487
D
Common Stock
2020-07-23
4
S
0
300
77.25
D
1985187
D
Common Stock
2020-07-23
4
S
0
325
78.52
D
1984862
D
Common Stock
2020-07-23
4
S
0
969
79.94
D
1983893
D
Common Stock
2020-07-23
4
S
0
1363
80.70
D
1982530
D
Common Stock
2020-07-23
4
S
0
11000
82.18
D
1971530
D
Common Stock
2020-07-24
4
S
0
500
68.19
D
1971030
D
Common Stock
2020-07-24
4
S
0
595
69.33
D
1970435
D
Common Stock
2020-07-24
4
S
0
1160
71.35
D
1969275
D
Common Stock
2020-07-24
4
S
0
1638
72.56
D
1967637
D
Common Stock
2020-07-24
4
S
0
1107
73.33
D
1966530
D
Common Stock
4116
I
By Valhalla, LLC
Stock Option (Right to Buy)
.99
2020-07-23
4
M
0
10000
0
D
2023-08-19
Common Stock
10000
877431
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.20 to $76.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.10 to $77.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.24 to $78.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.25 to $80.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.37 to $81.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.54 to $82.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.84 to $68.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.87 to $69.74 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.74 to $71.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.95 to $72.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.01 to $73.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option is fully vested and exercisable.
This option is fully vested and exercisable.
/s/ Lori Henderson, as Attorney-in-Fact
2020-07-27